Hemophilia A: all 885 studies
Page 8 of 9. Open to participants first (139), then studies with results posted, then the rest; newest registration first within each.
- Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet FunctionCompletedNCT02225483
- To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in JapanCompletedNCT02207218
- Transcultural Multidisciplinary Evaluation of Patients With HemophiliStatus unknownNCT02199639
- Manual Therapy in Haemophilic Arthropathy of the KneeCompletedNCT02198014Not applicable
- Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia.Status unknownNCT02197611
- Hemophilia Inhibitor Clinical Trials (INHIBIT) PlatformWithdrawnNCT02196207Phase 3
- Adherence to Treatment in HemophiliaStatus unknownNCT02191436
- Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBISCompletedNCT02190149
- China ADVATE PTP StudyCompletedNCT02170402Phase 4
- Assessment of Proprioceptive and Functional Characteristics in Patients With HemophiliaStatus unknownNCT02165592
- Individualized Prophylaxis for Severe Hemophilia A ChildrenStatus unknownNCT02116855Not applicable
- Allogenic Bone Marrow Derived Mesenchymal Stem Cell Therapy in Cases of HemophiliaStatus unknownNCT02108132Phase 1
- ADVATE 2 mL Post-Authorization Safety Surveillance (PASS)CompletedNCT02093741
- Platelet Function in Patients With Hemophilia ACompletedNCT02093065
- Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male SubjectsWithdrawnNCT02084810Phase 1
- ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)CompletedNCT02078427
- Web-based Application for the Population Pharmacokinetic Service - Phase 1CompletedNCT02061072
- Global Hemostatic Methods in Hemophilia and Von Willebrand's DiseaseStatus unknownNCT02061033
- A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia CareCompletedNCT02049099
- Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia BWithdrawnNCT02048111Phase 3
- A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B PatientsCompletedNCT02035605Phase 1
- Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia ACompletedNCT02035384
- Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia AStatus unknownNCT02027779Phase 3
- Case-control Pilot Study of the Immune Modulating Effect of FEIBA on Patients With Haemophilia A and InhibitorsStatus unknownNCT02018393
- Impact of Pain on Functional Impairment and Quality of Life in Adults With HemophiliaCompletedNCT01988532
- Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodiesNo longer availableNCT01968655
- Project to Update the Study of Congenital Haemophilia in SpainCompletedNCT01959555
- A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without InhibitorsCompletedNCT01949792Phase 1
- Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without InhibitorsCompletedNCT01921855Phase 1
- Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIaStatus unknownNCT01856751
- A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With InhibitorsCompletedNCT01830712
- Comparison of Efficacy, Safety and Costs of Recombinant FVIII Products Between On-demand and Secondary Prophylaxis Groups in Haemophilia A PatientsCompletedNCT01817868
- A Comparison Study of Bypassing Agent Therapy With and Without Tranexamic Acid in Haemophilia A Patients With InhibitorCompletedNCT01800435Phase 4
- Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia ACompletedNCT01775618Phase 3
- Viscosupplementation in Patients With Hemophilic ArthropathyCompletedNCT01748201Phase 4
- A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or BCompletedNCT01708564Phase 1
- Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia ACompletedNCT01692925Phase 1
- Comparative Pharmacokinetic Study of Two Different Strengths of BAY14-2222CompletedNCT01653639Phase 1
- Hemophilia Inhibitor Previously Untreated Patient StudyCompletedNCT01652027
- A Multi-centre, Open Labelled, Multiple Dosing Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC 0172-2021 Administered Subcutaneously to Healthy Male Subjects and Haemophilia SubjectsTerminatedNCT01631942Phase 1
- Personalized Prediction of Tolerance and Immunogenicity in HemophiliaStatus unknownNCT01626105
- A Phase 2/ 3 Trial to Evaluate the Efficacy and Safety of BAY86-6150CompletedNCT01625390Phase 2/3
- Quality of Life in Adult Patients With Severe Haemophilia in TurkeyStatus unknownNCT01623960
- Hemophilia B Gene Therapy With AAV8 VectorTerminatedNCT01620801Phase 1
- Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia AStatus unknownNCT01619046Phase 3
- BAX 855 Dose-Escalation Safety StudyCompletedNCT01599819Phase 1
- Study on Von Willebrand Disease and Hemophilia in Cuenca, EcuadorCompletedNCT01589848
- Non-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With InhibitorsCompletedNCT01586936
- Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing SurgeryCompletedNCT01579968
- Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical PracticeCompletedNCT01579955
- Relative Bioavailability Of Two Formulations Of Moroctocog Alfa (AF-CC)CompletedNCT01579903Phase 1
- Inhibitor Development in Patients With Hemophilia A Undergoing SurgeryCompletedNCT01571934
- Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia ACompletedNCT01568580Phase 3
- Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy VolunteersCompletedNCT01563471Phase 1
- Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding StateCompletedNCT01562587Phase 1
- Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding StateCompletedNCT01562457Phase 1
- Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of ThromboelastographyCompletedNCT01561924Phase 1
- Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male SubjectsCompletedNCT01561417Phase 1
- Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major SurgeryCompletedNCT01561391Phase 4
- Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese SubjectsCompletedNCT01555749Phase 1
- Non Neutralizing Antibodies: Prevalence and CharacterizationWithdrawnNCT01541527
- Socialization of Adult Men With Congenital Hemophilia A or BCompletedNCT01510418
- Thrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With InhibitorsStatus unknownNCT01505946
- Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing CountriesCompletedNCT01503567
- Internet-based Educational Program to Promote Self-Management for Teens With HemophiliaCompletedNCT01477437Not applicable
- Osteoporosis and MRI Study in HemophiliaTerminatedNCT01460147Not applicable
- Study of Biostate for Treatment of Children With Hemophilia A Complicated by Antibody DevelopmentTerminatedNCT01445197Phase 3
- Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A PatientsCompletedNCT01436825
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareCompletedNCT01431326
- Turkish Acquired Haemophilia RegistryStatus unknownNCT01403740
- Kogenate FS Regulatory Post-Marketing SurveillanceCompletedNCT01386268
- A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia ACompletedNCT01365520Phase 1
- Survey Evaluating the Psychosocial Effects of Living With HaemophiliaCompletedNCT01322620
- Biomarkers Serum Collection Methodology Pilot StudyCompletedNCT01318707
- Cardiovascular Disease (CVD) in HaemophiliaStatus unknownNCT01303900
- Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B PatientsCompletedNCT01288391Phase 1
- Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired HaemophiliaCompletedNCT01285089
- Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male SubjectsCompletedNCT01272206Phase 1
- A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543CompletedNCT01238367Phase 1
- Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and InhibitorsCompletedNCT01234545
- Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein in Subjects With Hemophilia BCompletedNCT01233440Phase 1
- Validation of Ultrasound as a Diagnostic Tool for Assessment of Hemophilic Arthropathy of Knees and AnklesCompletedNCT01232634
- Study of Biostate® in Children With Hemophilia ACompletedNCT01229007Phase 3
- Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or BCompletedNCT01228669Phase 1
- Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or BCompletedNCT01220141
- Comparing the Burden of Illness of Hemophilia in the Developing and the Developed WorldCompletedNCT01217255
- Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia ACompletedNCT01205724Phase 1
- First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia PatientsTerminatedNCT01191372Phase 1
- Trial to Evaluate the Pharmacokinetics and Safety Profile of BAY94-9027 Following Single and Multiple Dose AdministrationCompletedNCT01184820Phase 1
- Prophylaxis Versus On-demand Therapy Through Economic ReportCompletedNCT01159587
- IMMUNINE Pre-Treatment StudyCompletedNCT01128881Phase 4
- rFVIIa Prophylaxis in Children With Hemophilia A and InhibitorsStatus unknownNCT01105546Phase 2
- Correlation Between Vitamin D Status and Bone Mineral Density in Patients With HemophiliaCompletedNCT01090206Not applicable
- Quality of Life Study of Helixate NexGenCompletedNCT01053715
- Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. NaiveWithdrawnNCT01051544Not applicable
- Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced)CompletedNCT01051076Not applicable
- Health Related Quality of Life of Youth and Young Adults With Hemophilia ACompletedNCT01034904
- Bleeding Symptoms of Carriers of Hemophilia A and BCompletedNCT01029808
- Study of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia ACompletedNCT01027377Phase 1
- Joint Outcome Study Continuation for Children With Severe Factor VIII DeficiencyCompletedNCT01000844